Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanjing Zeng

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Medicinal Chemistry|December 26, 2025
HDAC and PI3K dual inhibitors in the treatment of cancers: Current status, trends, and solutionsWanjing Zeng, Zhe Zhang, Kaiyin Li, et al.
Journal of Medicinal Chemistry|December 15, 2025
Discovery of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent PI3K/mTOR Dual Inhibitors for the Treatment of Pulmonary FibrosisWanjing Zeng, Xiaoyuan Hua, Zhengyang Wang, et al.
European Journal of Medicinal Chemistry|November 2, 2025
Development of PI3K/mTOR-HSP90 ligand conjugates for improved colorectal cancer therapyZhengyang Wang, Xiaoyuan Hua, Chuchu Li, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
PI3K/mTOR Inhibitor Induces Context-Dependent Apoptosis and Methuosis in Cancer CellsXiaoyuan Hua, Panpan Chen, Wanjing Zeng, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Medicinal Chemistry|December 26, 2025
HDAC and PI3K dual inhibitors in the treatment of cancers: Current status, trends, and solutionsWanjing Zeng, Zhe Zhang, Kaiyin Li, et al.
Journal of Medicinal Chemistry|December 15, 2025
Discovery of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent PI3K/mTOR Dual Inhibitors for the Treatment of Pulmonary FibrosisWanjing Zeng, Xiaoyuan Hua, Zhengyang Wang, et al.
European Journal of Medicinal Chemistry|November 2, 2025
Development of PI3K/mTOR-HSP90 ligand conjugates for improved colorectal cancer therapyZhengyang Wang, Xiaoyuan Hua, Chuchu Li, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
PI3K/mTOR Inhibitor Induces Context-Dependent Apoptosis and Methuosis in Cancer CellsXiaoyuan Hua, Panpan Chen, Wanjing Zeng, et al.
Pageof 1